/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.
TTM free cash flow is negative (-$21M). Projecting from a negative base produces nonsense, so this model uses the average of the last three positive years ($14M) instead. Treat every figure here as a rough estimate that assumes a return to historical profitability.
Conservative
$6.18
0% undervaluedvs $0.00
Base
$8.66
0% undervaluedvs $0.00
Optimistic
$14.27
0% undervaluedvs $0.00
Today's price falls outside the modelled range.
Base free cash flow
$14M
3-year average, TTM negative
Historical FCF CAGR
+0.0%
Across 6 reported periods
Market implies
—
No solution in range
Terminal value share
62%
Of the base case valuation
No growth rate in the tested range reproduces today's price at these assumptions.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
The most recent period is the base every projection starts from. Compounded, that history is +0.0% a year.
Intrinsiqq's two-stage DCF values Zynex (ZYXIQ) at about $11.54 per share, or $8.66 with a 25% margin of safety. Every assumption is adjustable below; this is analysis, not investment advice.
Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about $11.54 per share for ZYXIQ. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $8.66. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.
SourceFair value computed from the 10-Q filed 17 Nov 2025, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 6 Jun 2026. How this is calculated.
Fiscal year ends Dec.
The base case grows ZYXIQ's free cash flow at about 8.0% a year before fading. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.
A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns ZYXIQ's $11.54 intrinsic estimate into a $8.66 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from SEC filings, not investment advice.